中国血吸虫病防治杂志 ›› 2012, Vol. 24 ›› Issue (4): 474-477.

• 短篇论著 • 上一篇    下一篇

中国中部地区间日疟原虫分离株Duffy血型结合蛋白II区的克隆 表达与初步鉴定

刘丹1,2|夏惠1,2|陶志勇1,2*|陈勇2|方强1,2|王雪梅1,2|孙新1,2|高颖1,2|买月琴2   

  1. 1 蚌埠医学院病原生物学教研室 (蚌埠 233030); 2 安徽省感染与免疫重点实验室
  • 出版日期:2012-08-15 发布日期:2012-08-15
  • 通讯作者: 陶志勇
  • 作者简介:刘丹| 女| 硕士研究生。研究方向: 寄生虫感染与免疫
  • 基金资助:

    卫生部寄生虫病预防与控制技术重点实验室开放课题(WK009?001); 安徽省高等学校省级自然科学研究重点项目 (KJ2012A200)

Cloning|expression and identification of Plasmodium vivax Duffy binding protein region II of central China isolate

LIU Dan1,2|XIA Hui1,2|TAO Zhi-yong1,2*|CHEN Yong2|FANG Qiang1,2|WANG Xue-mei1,2|SUN Xin1,2|GAO Ying1,2|MAI Yue-qin2   

  1. 1 Department of Microbiology and Parasitology|Bengbu Medical College|Bengbu 233030|China;2 Anhui Key Laboratory of Infection and Immunity| China
  • Online:2012-08-15 Published:2012-08-15
  • Contact: TAO Zhi-yong

摘要:

目的 克隆中国中部地区间日疟原虫分离株Duffy血型结合蛋白II区基因 (PvDBPII), 体外表达和鉴定重组 PvDBPII蛋白。方法 PCR法从间日疟患者血液DNA样品中扩增PvDBPII基因, 将产物插入到原核表达载体pET28a (+)中, 构建pET28a?PvDBPII重组表达质粒, 转化大肠埃希菌 (E. coli) BL21 (DE3+), 异丙基?β?D?硫代吡喃半乳糖苷诱导表达带有His标签的重组蛋白, 采用镍柱亲和层析纯化重组蛋白, 相应表达物分别采用十二烷基磺酸钠?聚丙烯酰胺凝胶电泳和 Western blot进行分析鉴定。结果 PCR扩增的PvDBPII基因为1.1 kb, 重组pET28a?PvDBPII质粒经测序验证, 其插入片段序列与GenBank参考序列相似性为99%, 转化E. coli所表达的重组蛋白分子量约为44 kDa, 且能被间日疟患者血清特异性识别。结论 成功克隆了PvDBPII基因, 表达了重组PvDBPII蛋白, 为进一步研究基于PvDBPII的红内期间日疟疫苗奠定了基础

关键词: 间日疟原虫; 疟疾; Duffy血型结合蛋白; 原核表达; 疫苗; 中国

Abstract:

Objective To clone a Plasmodium vivax Duffy binding protein critical functional region II(PvDBPII)gene of central China isolate,and to express and identify the recombinant PvDBPII protein in vitro. Methods PCR was performed to am? plify PvDBPII from P. vivax DNA of a central China isolate and the PCR product was inserted into pET28a (+)vector. pET28a? PvDBPII recombinant plasmid was constructed and transformed into E. coli host BL21 (DE3+) . IPTG was used to induce the recom? binant PvDBPII protein fused with His tag,and the protein was purified by His?NTA affinity chromatography. The recombinant pro? tein was identified by SDS?PAGE and Western blot. Results The PCR product of PvDBPII gene was about 1.1 kb,meeting the expectation of predicted fragment size. The recombinant pET28a?PvDBPII plasmid was verified by sequencing that the insertion was correct both in direction and in frame,but with 4 non?synonymous mutations compared to reference P. vivax strain Sal?I. SDS? PAGE,and Western blot analysis showed that the recombinant PvDBPII protein was about 44 kDa,and could be recognized by pooled sera from vivax malaria patients. Conclusion The PvDBPII gene of central China isolate is successfully cloned,and re? combinant PvDBPII is expressed, thereby providing opportunity for further study on PvDBPII.

Key words: Plasmodium vivax;Malaria;PvDBPII; Prokaryotic expression; Vaccine; China

中图分类号: